Cargando…

ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample

BACKGROUND: Dopamine is believed to be a key neurotransmitter in the development of attention-deficit/hyperactivity disorder (ADHD). Several recent studies point to an association of the dopamine D4 receptor (DRD4) gene and this condition. More specifically, the 7 repeat variant of a variable number...

Descripción completa

Detalles Bibliográficos
Autores principales: Krämer, Ulrike M, Rojo, Nuria, Schüle, Rebecca, Cunillera, Toni, Schöls, Ludger, Marco-Pallarés, Josep, Cucurell, David, Camara, Estela, Rodriguez-Fornells, Antoni, Münte, Thomas F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803796/
https://www.ncbi.nlm.nih.gov/pubmed/20021692
http://dx.doi.org/10.1186/1471-2202-10-150
_version_ 1782176073854746624
author Krämer, Ulrike M
Rojo, Nuria
Schüle, Rebecca
Cunillera, Toni
Schöls, Ludger
Marco-Pallarés, Josep
Cucurell, David
Camara, Estela
Rodriguez-Fornells, Antoni
Münte, Thomas F
author_facet Krämer, Ulrike M
Rojo, Nuria
Schüle, Rebecca
Cunillera, Toni
Schöls, Ludger
Marco-Pallarés, Josep
Cucurell, David
Camara, Estela
Rodriguez-Fornells, Antoni
Münte, Thomas F
author_sort Krämer, Ulrike M
collection PubMed
description BACKGROUND: Dopamine is believed to be a key neurotransmitter in the development of attention-deficit/hyperactivity disorder (ADHD). Several recent studies point to an association of the dopamine D4 receptor (DRD4) gene and this condition. More specifically, the 7 repeat variant of a variable number of tandem repeats (VNTR) polymorphism in exon III of this gene is suggested to bear a higher risk for ADHD. In the present study, we investigated the role of this polymorphism in the modulation of neurophysiological correlates of response inhibition (Go/Nogo task) in a healthy, high-functioning sample. RESULTS: Homozygous 7 repeat carriers showed a tendency for more accurate behavior in the Go/Nogo task compared to homozygous 4 repeat carriers. Moreover, 7 repeat carriers presented an increased nogo-related theta band response together with a reduced go-related beta decrease. CONCLUSIONS: These data point to improved cognitive functions and prefrontal control in the 7 repeat carriers, probably due to the D4 receptor's modulatory role in prefrontal areas. The results are discussed with respect to previous behavioral data on this polymorphism and animal studies on the impact of the D4 receptor on cognitive functions.
format Text
id pubmed-2803796
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28037962010-01-10 ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample Krämer, Ulrike M Rojo, Nuria Schüle, Rebecca Cunillera, Toni Schöls, Ludger Marco-Pallarés, Josep Cucurell, David Camara, Estela Rodriguez-Fornells, Antoni Münte, Thomas F BMC Neurosci Research article BACKGROUND: Dopamine is believed to be a key neurotransmitter in the development of attention-deficit/hyperactivity disorder (ADHD). Several recent studies point to an association of the dopamine D4 receptor (DRD4) gene and this condition. More specifically, the 7 repeat variant of a variable number of tandem repeats (VNTR) polymorphism in exon III of this gene is suggested to bear a higher risk for ADHD. In the present study, we investigated the role of this polymorphism in the modulation of neurophysiological correlates of response inhibition (Go/Nogo task) in a healthy, high-functioning sample. RESULTS: Homozygous 7 repeat carriers showed a tendency for more accurate behavior in the Go/Nogo task compared to homozygous 4 repeat carriers. Moreover, 7 repeat carriers presented an increased nogo-related theta band response together with a reduced go-related beta decrease. CONCLUSIONS: These data point to improved cognitive functions and prefrontal control in the 7 repeat carriers, probably due to the D4 receptor's modulatory role in prefrontal areas. The results are discussed with respect to previous behavioral data on this polymorphism and animal studies on the impact of the D4 receptor on cognitive functions. BioMed Central 2009-12-20 /pmc/articles/PMC2803796/ /pubmed/20021692 http://dx.doi.org/10.1186/1471-2202-10-150 Text en Copyright ©2009 Krämer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Krämer, Ulrike M
Rojo, Nuria
Schüle, Rebecca
Cunillera, Toni
Schöls, Ludger
Marco-Pallarés, Josep
Cucurell, David
Camara, Estela
Rodriguez-Fornells, Antoni
Münte, Thomas F
ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
title ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
title_full ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
title_fullStr ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
title_full_unstemmed ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
title_short ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
title_sort adhd candidate gene (drd4 exon iii) affects inhibitory control in a healthy sample
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803796/
https://www.ncbi.nlm.nih.gov/pubmed/20021692
http://dx.doi.org/10.1186/1471-2202-10-150
work_keys_str_mv AT kramerulrikem adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT rojonuria adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT schulerebecca adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT cunilleratoni adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT scholsludger adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT marcopallaresjosep adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT cucurelldavid adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT camaraestela adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT rodriguezfornellsantoni adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample
AT muntethomasf adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample